On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Eli Lilly (Spain)

InstitutionResearch output, impact & collaborations

Eli Lilly (Spain) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Eli Lilly (Spain)?

ScholarIQrecord summary

Eli Lilly (Spain) is a research organisation in Alcobendas, ES. OpenAlex records 1,038 works and 87,130 citations for it. 284 researchers list it as their most recent affiliation.

How many works does Eli Lilly (Spain) have?

ScholarIQindexed works

Eli Lilly (Spain) has 1,038 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Eli Lilly (Spain) have?

ScholarIQcitation count

Eli Lilly (Spain) has 87,130 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Eli Lilly (Spain)?

ScholarIQresearcher count

Eli Lilly (Spain) has 284 researchers in the ScholarIQ index.

What is the average h-index at Eli Lilly (Spain)?

ScholarIQavg h-index

Eli Lilly (Spain) has an average h-index of 16 in OpenAlex.

What is the ROR of Eli Lilly (Spain)?

ScholarIQror

The ROR for Eli Lilly (Spain) is on the source record.

What is the OpenAlex record for Eli Lilly (Spain)?

ScholarIQopenalex

The OpenAlex for Eli Lilly (Spain) is on the source record.

Who are the most-cited researchers behind Eli Lilly (Spain)?

ScholarIQtop researchers by citations
1
Silvia Díaz‐Cerezo · Diabetes Treatment and Management
89 works838 citations

What are the most-cited papers on Eli Lilly (Spain)?

ScholarIQmost cited works
Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic Review
Manuel Barreiro‐de Acosta, Alberto Molero, Esther Artime, Silvia Díaz‐Cerezo, Luís Lizán, Héctor D. de Paz, María Dolores Martín‐Arranz
Advances in Therapy. 202375 CitationsOPEN ACCESS
Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study
Pablo Irimia, David García‐Azorín, Mercedes Núñez, Silvia Díaz‐Cerezo, Pepa Polavieja, Tommaso Panni, Aram Sicras-Navarro, Antoni Sicras‐Mainar, Antonio Ciudad
The Journal of Headache and Pain. 202248 CitationsOPEN ACCESS
Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature
José Antonio Sacristán, Tatiana Dilla, Silvia Díaz‐Cerezo, Clara Gabás‐Rivera, Susana Aceituno, Luís Lizán
PLoS ONE. 202046 CitationsOPEN ACCESS
New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care
Miguel J. A. Láinez, Jesús Castillo, Manuel Domínguez, Gemma Palacios, Silvia Díaz‐Cerezo, Javier Rejas
BMC Neurology. 201042 CitationsOPEN ACCESS
Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review
Esther Artime, Irene Romera, Silvia Díaz‐Cerezo, Elías Delgado
Diabetes Therapy. 202141 CitationsOPEN ACCESS

How much of the research on Eli Lilly (Spain) is open access?

ScholarIQopen access share
64%OPEN ACCESS
Gold
55%
Green
0%
Hybrid
9%
Bronze
0%
Closed
36%

Related on ScholarIQ

470M+ articles · 14-day free trial